Cargando…
Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways
BACKGROUND: Inhibitor of DNA binding 1 (Id1) is upregulated in multiple cancers, and Id1overexpression correlates with cancer aggressiveness and poor clinical outcomes in cancer patients. However, its roles in cancer stem-like cells (CSCs) and epithelial-mesenchymal transition (EMT) are still elusiv...
Autores principales: | Sun, Yanxia, Lai, Xiaolan, Yu, Yue, Li, Jieyu, Cao, Lei, Lin, Wansong, Huang, Chuanzhong, Liao, Jinrong, Chen, Wei, Li, Chao, Yang, Chunkang, Ying, Mingang, Chen, Qiang, Ye, Yunbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664424/ https://www.ncbi.nlm.nih.gov/pubmed/31440083 http://dx.doi.org/10.2147/CMAR.S207167 |
Ejemplares similares
-
Hearing Loss in Id1(−/−); Id3(+/−) and Id1(+/−); Id3(−/−) Mice Is Associated With a High Incidence of Middle Ear Infection (Otitis Media)
por: Zheng, Qingyin, et al.
Publicado: (2021) -
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012) -
ID Track 1/2
por: Stenson, Kevin
Publicado: (2011) -
ID’ing a Novel Inhibitor of β-Cell Function, Id1
por: Billestrup, Nils
Publicado: (2011) -
Combined Id1 and Id3 Deletion Leads to Severe Erythropoietic Disturbances
por: Zhao, Qingshi, et al.
Publicado: (2016)